ELIZABETH MANNING: Open Payments
NPI 1942759329 · WASHINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 9 payments from 5 companies in 2025. Trend: 2023 $106 · 2024 $97 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $167 |
| Indivior Inc. | 2 | $43 |
| Dexcom, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $17 |
Products named: REPATHA, SUBLOCADE, Dexcom G6 Transmitter, OTEZLA, UZEDY, ELIQUIS.
Industry payments across NC — which companies pay providers there.
